Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors

NCT00765973 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer
Ovarian Cancer
Solid Tumors

Interventions

DRUG: Topotecan Liposomes Injection (TLI)
DRUG: Topotecan Liposomes Injection (TLI)

Sponsor

Spectrum Pharmaceuticals, Inc